MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
Castle Biosciences ROCE Ratio 2011-2026 | CSTL
Annual ROCE Ratio Castle Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.9 | -17.37 | -18.25 | -9.73 | -1.56 | 7.02 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.02 | -18.25 | -6.33 |
Quarterly ROCE Ratio Castle Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.58 | -4.97 | -2.86 | 0.97 | -1.52 | -5.17 | -11.94 | -16.27 | -21.5 | -24.24 | -19.59 | -12.35 | -15.22 | -12.85 | -14.03 | -6.01 | -6.95 | -5.02 | -3.06 | -0.84 | 4.36 | 10.5 | 11.37 | 5.54 | 10.58 | 10.42 | 14.42 | 9.76 | 9.76 | 4.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.42 | -24.24 | -3.32 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 118.69 | -0.89 % | $ 36.1 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 21.75 | 5.79 % | $ 234 M |  China |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 22.48 | 27.95 % | $ 1.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.44 | 1.41 % | $ 1.92 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 180.08 | -0.32 % | $ 8.93 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 194.49 | -1.82 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 2.2 | - | $ 9.73 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 524.38 | 1.13 % | $ 15.1 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 132.01 | -0.19 % | $ 21 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.19 | -5.65 % | $ 1.05 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.27 | -1.59 % | $ 2.01 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.18 | 0.06 % | $ 489 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 28.77 | -1.03 % | $ 20 B |  Niderland |
 |
Guardant Health
GH
|
440.3 | $ 85.06 | 0.24 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.82 | -3.75 % | $ 91.5 K | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.18 | 3.32 % | $ 5.01 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 117.75 | 1.07 % | $ 9.71 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 267.87 | 0.36 % | $ 22.3 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.8 | -1.45 % | $ 284 M | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
-171.24 | $ 125.92 | 1.98 % | $ 5.89 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.59 | 0.03 % | $ 2.67 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 5.11 | -1.64 % | $ 473 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 82.82 | -1.34 % | $ 5.59 B | USA |
 |
Neuronetics
STIM
|
-140.48 | $ 1.4 | 0.42 % | $ 92.3 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 192.41 | 0.56 % | $ 21.4 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 5.17 | 0.58 % | $ 4.07 M | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 519.51 | -2.26 % | $ 196 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.69 | -1.42 % | $ 61.9 M | Irlanda |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |